XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Statements Of Cash Flows - USD ($)
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Operating Activities      
Net income (loss) $ (6,217,237) $ (23,952,037) $ (40,744,938)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation, depletion and amortization 7,745,804 11,313,783 18,196,583
Impairment of producing properties 50,475 29,904,528 76,824,337
Provision for deferred income taxes (985,101) (4,647,000) (12,112,000)
Gain from leasing fee mineral acreage (421,915) (685,927) (1,546,298)
Proceeds from leasing fee mineral acreage 441,653 701,948 1,565,649
Net (gain) loss on sales of assets (309,348) (3,973,321) (18,730,197)
ESOP contribution expense   103,104 372,274
Directors' deferred compensation expense 234,466 228,408 272,491
Total (gain) loss on derivative contracts 16,202,489 (907,419) (6,105,145)
Cash receipts (payments) on settled derivative contracts (11,925,669) 4,109,210 196,985
Restricted stock awards 801,200 743,897 771,797
Loss on debt extinguishment 260,236    
Other (11,099) (2,611) 19,085
Cash provided (used) by changes in assets and liabilities:      
Natural gas, oil and NGL sales receivables (3,485,762) 1,434,426 2,723,983
Refundable income taxes 1,391,285 (2,299,785) (1,472,277)
Other current assets (436,401) (89,931) 21,116
Accounts payable (151,875) 1,308,731 105,217
Other non-current assets (86,282) (1,044,680) 7,166
Accrued liabilities 845,168 (1,139,029) 639,856
Total adjustments 10,159,324 35,058,332 61,750,622
Net cash provided by operating activities 3,942,087 11,106,295 21,005,684
Investing Activities      
Capital expenditures (733,172) (403,136) (3,526,007)
Acquisition of minerals and overriding royalty interests (20,624,347) (10,288,250) (5,662,869)
Investments in partnerships     (1,648)
Proceeds from sales of assets 988,600 4,228,868 19,515,735
Net cash provided (used) by investing activities (20,368,919) (6,462,518) 10,325,211
Financing Activities      
Borrowings under Credit Facility 26,300,000 6,061,725 16,642,481
Payments of loan principal (37,550,000) (12,736,725) (32,217,481)
Net proceeds from equity issuance 11,688,137 8,220,726  
Cash receipts from (payments on) off-market derivative contracts 8,800,000    
Purchases of treasury stock (2,741) (7,635) (7,454,000)
Payments of dividends (1,060,448) (1,652,164) (2,673,706)
Net cash provided (used) by financing activities 8,174,948 (114,073) (25,702,706)
Increase (decrease) in cash and cash equivalents (8,251,884) 4,529,704 5,628,189
Cash and cash equivalents at beginning of year 10,690,395 6,160,691 532,502
Cash and cash equivalents at end of year 2,438,511 10,690,395 6,160,691
Supplemental Disclosures of Cash Flow Information      
Interest paid (net of capitalized interest) 1,021,142 1,306,967 2,031,762
Income taxes paid (net of refunds received) (1,391,225) (1,342,275) 103,279
Supplemental schedule of noncash investing and financing activities:      
Additions and revisions, net, to asset retirement obligations   4 27,782
Gross additions to properties and equipment 31,485,015 10,701,284 9,248,415
Equity offering used for acquisitions (10,272,288)    
Net (increase) decrease in accounts payable for properties and equipment additions 144,792 (9,898) (59,539)
Capital expenditures, including dry hole costs $ 21,357,519 $ 10,691,386 $ 9,188,876